News
In line with MIT and Recursion’s commitment to making AI tools accessible for drug developers, Boltz-2 will be open-sourced under an MIT license, making the model, weights, and training pipeline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback